Biocon Ltd, an innovation-led global biopharmaceuticals company, today announced that the Board of its subsidiary Biocon Biologics India Ltd has approved a primary equity investment by True North. As per the terms of the proposed agreement, True North will invest ₹ 536.25 Crore that will eventually translate to a 2.44% minority stake in the biosimilars…